Rapidly growing Petauri Health adds exceptional talent to its executive roster. NEW YORK September 21, 2023 — Petauri Health, a New York-based, purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks with 3 experienced leaders who straddle information technology, operations, and finance. Jeff Petet, CHCIO, has been named SVP, Information…
Rapidly growing Petauri Health adds top talent to its executive team NEW YORK July 12, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has named Mridul Malhotra to the dual role of Chief Strategic Officer (CSO) and Global Head: Evidence, Value, and Access (EVA). In this newly created…
Petauri Health’s initial acquisition marks a key milestone in its mission to offer integrated commercialization solutions. NEW YORK June 13, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has acquired The Kinetix Group, also known as TKG. Founded by John Strapp and Sarah McNulty, The Kinetix Group is…
PM360 asked experts in developing market access strategies how the Inflation Reduction Act will impact drug pricing negotiation and other access-related issues as well as what other big trends in the space will force the industry to rethink its strategies. See how our own Dan Renick responded:
Oak Hill Capital and life sciences industry leader Dan Renick team up to create new organization offering integrated commercialization solutions. NEW YORK February 1st, 2023 – Oak Hill Capital, a New York-based middle-market private equity firm, announced today that it has partnered with Dan Renick to launch Petauri Health (“Petauri” or “the Company”), a purpose-built…